BIOS Fund II, LP
SEC CIK 1714576 · EDGAR
BoughtSold
Most active insiders at ACTU, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | THOMSON TODD S | Dir, 10% | — | $1.62M |
| 2 | SCHMITT DANIEL M | Pres, CEO, Dir | — | — |
BIOS Fund II, LP made no open-market trades at ACTU in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-06-30 | 2025-06-27 | ACTU | ACTUATE THERAPEUTICS, INC. | BIOS Fund II, LP | Dir, 10% | P - Purchase | $7.00 | +71.4K | 196.4K | +57% | +$500.0K |
| MAI | 2024-08-20 | 2024-08-14 | ACTU | ACTUATE THERAPEUTICS, INC. | BIOS Fund II, LP | Dir, 10% | S - Sale | $8.00 | -25.0K | 980.4K | -2% | -$200.0K |
| DMI | 2022-09-07 | 2022-09-02 | LTRN | Lantern Pharma Inc. | BIOS Fund II, LP | 10% | X - OptEx | $1.03 | +32.5K | 26.1K | New | +$33.5K |
| DMI | 2022-09-07 | 2022-09-02 | LTRN | Lantern Pharma Inc. | BIOS Fund II, LP | 10% | S - Sale+OE | $5.20 | -6,445 | 20.9K | -24% | -$33.5K |
| MI | 2022-08-17 | 2022-08-16 | INAB | IN8BIO, INC. | BIOS Fund II, LP | Dir, 10% | P - Purchase | $1.90 | +1.77M | 540.3K | New | +$3.37M |
Purchase Sale Sale after option exercise All abbreviations